Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks ...

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

Cardinal Health CEO Jason Hollar recounted the ... expands its profitable business delivering medical supplies for at-home care. Altogether the four acquisitions in 2024 total $6.2 billion.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) in Q4 CY2024, but sales fell by 3.8% year on year to ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...

Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that ...

Cardinal Health gets downgraded to a hold ... physician offices, and patients in the home." Since my last article, the stock has gone up +15% as of today, and at the time of my bullish call ...

Re-Segmenting Cardinal Health’s Business Cardinal Health has ... OptiFreight, Nuclear and At-Home divisions.” Breaking these out has allowed the company to shine a spotlight on each area ...

DUBLIN, Ohio, Jan. 14, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced construction is underway on a new distribution center in Fort Worth, Texas, which will support its at-Home ...